Top Story

Abatacept improves patient-reported outcomes in psoriatic arthritis

December 18, 2018

ACR, National Psoriasis Foundation stress treat-to-target, TNF inhibitors in PsA guidelines

December 3, 2018
Physicians should use a treat-to-target approach, as well as TNF inhibitor biologics as a first-line therapy, in all patients with active psoriatic arthritis, according…
Meeting News

Bimekizumab improves outcomes among PsA patients

November 27, 2018
CHICAGO — Bimekizumab, a monoclonal antibody that neutralizes both IL-17A and IL-17F, significantly improved both musculoskeletal and skin outcomes among patients…
In the Journals

Psychiatric disorders, CVD, IBD more prevalent in psoriasis with PsA

November 21, 2018
Cardiovascular disease, psychiatric disorders and inflammatory bowel disease are more prevalent among patients with both psoriasis and psoriatic arthritis, compared with…
More Headlines »
Healio Jobs